You are here

  • Home
  • Archive
  • Volume 19, Issue 5
  • Radiofrequency ablation of Barrett's oesophagus with confirmed low-grade dysplasia reduces risk of development of high-grade dysplasia and adenocarcinoma

Article info

Article menu
Download PDFPDF
Prevention
Randomised controlled trial
Radiofrequency ablation of Barrett's oesophagus with confirmed low-grade dysplasia reduces risk of development of high-grade dysplasia and adenocarcinoma

Authors

  • Christine P J Caygill UK National Barrett's Oesophagus Registry, Royal Free Campus, University College London, London, UK; PubMed articlesGoogle scholar articles
  • Piers A C Gatenby UK National Barrett's Oesophagus Registry, Royal Free Campus, University College London, London, UK; Regional Oesophagogastric Unit, Royal Surrey County Hospital, Guildford, UK PubMed articlesGoogle scholar articles
  1. Correspondence to : Dr Christine PJ Caygill, UK National Barrett's Oesophagus Registry, Royal Free Campus, University College London, London NW32PF, UK; c.caygill{at}ucl.ac.uk
View Full Text

Citation

Caygill CPJ, Gatenby PAC
Radiofrequency ablation of Barrett's oesophagus with confirmed low-grade dysplasia reduces risk of development of high-grade dysplasia and adenocarcinoma
BMJ Evidence-Based Medicine 2014;19:185.

Publication history

  • First published July 9, 2014.
Online issue publication 
August 16, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions